As per the research report, the size of the North America Microbiology Testing/Clinical Microbiology Market is valued at USD 1.77 billion in 2023 and is expected to be growing at a CAGR of 13.12%, to touch USD 3.28 billion by 2028 during the forecast period 2023 to 2028.
The increasing incidence of contagious diseases such as HIV, Hepatitis B and C, human papillomavirus, and some forms of STDs increase the demand for the microbiology testing market.
Microbiology has remained a popular branch of medicine. Microbiology also works to promote health while dealing with clinical applications of bacteria, which is projected to drive the microbiology testing market.
The technological advancements in microbiology ensure significant market growth because various emerging techniques are used for early detection and the effective treatment of pathogen-borne diseases. However, these techniques offer various technological benefits, including better accuracy, faster turnaround time, and increased devices sensitivity compared to traditional laboratory approaches. Furthermore, as end-user preferences change, many notable product manufacturers create and commercialize unique and technologically advanced molecular diagnostic solutions for infectious disease detection.
The initiatives and funds by the government for the development of healthcare infrastructure, such as the establishment of clinical labs, hospitals are some other key factors bolstering the microbiological testing market growth.
Moreover, the recent global pandemic COVID-19 has significantly increased the demand for the microbiology testing market.
Increasing initiatives and funds by the government and non-government organizations in research and development activities and infrastructure development in the region are proving the way for new market entrants.
Other factors such as the availability of the advanced health sector and the critical emerging product manufacturers are propelling the market growth. In addition, the development and commercialization of pathogen-specific reagent/diagnostic kits have resulted in improved sample usage and the adoption of a well-defined clinical technique for specific disease diagnoses.
However, the high cost of equipment used in the microbiology test and the lack of skilled professionals significantly hamper the market growth. In addition, the surge in real-time technological challenges is also impeding market demand. Strict government restrictions for approving new products are also projected to hinder market growth.
This research report on the North America Microbiology Testing/Clinical Microbiology Market has been segmented and sub-segmented into the following categories:
By Microbiology Application:
By Clinical Application:
Rest of North America
Geographically, North America dominated the microbiology testing market, and it is most likely to continue its dominance throughout the forecast period. The regional market growth is linked to a well-established healthcare sector, increasing healthcare spending, and favorable reimbursement policies. In addition, the key market players in the region are adopting various market strategies such as mergers and acquisitions are predicted to expand the North American regional market growth.
The U.S microbiology testing market accounted for the largest share of the market, and it is anticipated to register a prominent claim during the forecast period. The U.S witnessed the high penetration of clinical microbiology technologies and significant distribution channels propelling the market growth. Also, manufacturers and industry players focus on research and development activities expected to provide lucrative growth opportunities in the market. In addition, the growing geriatric population, rising awareness about blood-related disorders, and surge in healthcare expenditure are boosting the market growth.
On the other, the Canadian microbiology testing market is projected to witness a promising share during the forecast period. The increasing prevalence of infectious diseases, Supportive government regulations, increasing investments, and funding by the government is contributing to the market growth.
KEY MARKET PLAYERS
Companies playing a dominant role in the North America Microbiology Testing/Clinical Microbiology Market profiled in this report are Danaher Corporation (U.S.), Becton, Dickinson, and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.), among others.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]